About Leon Moulder, Jr.
Form D filings for Interius BioTherapeutics from 2020 to 2024 list Leon Moulder, Jr. as director.
Leon Moulder, Jr. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Leon Moulder, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Leon Moulder, Jr. works with at each company, as listed on that company's latest Form D.
Interius BioTherapeutics, Inc. · Form D, Jun 3, 2024
TK
Tomas Kiselak
Director
BC
Bihua Chen
Director
DM
Dora Mitchell
Executive officer
PD
Philip Johnson, M.D.
President and Chief Executive Officer, director